Logo image
Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis
Journal article   Open access   Peer reviewed

Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis

Bryan Renslo, Ari Greis, Conan S Liu, Anjithaa Radakrishnan and Asif M Ilyas
Curēus (Palo Alto, CA), v 14(1), pp e21564-e21564
24 Jan 2022
PMID: 35228923
url
https://doi.org/10.7759/cureus.21564View
Published, Version of Record (VoR) Open

Abstract

Orthopedics Pain Management Physical Medicine & Rehabilitation
Background Osteoarthritis (OA) can result in significant pain, requiring pain management with opioids. Medical cannabis (MC) has the potential to be an alternative to opioids for chronic pain conditions. This study investigates whether MC used in the management of OA-related chronic pain can reduce opioid utilization. Methods Forty patients with chronic OA pain were certified for MC. Average morphine milligram equivalents (MME) per day of opioid prescriptions filled within the six months prior to MC certification was compared to that of the six months after. Visual analog scale (VAS) for pain and Global Health scores were measured at baseline, three, and six months post MC certification. Results Average MME/day decreased from 18.2 to 9.8 (n=40, p<0.05). The percentage of patients who dropped to 0 MME/day was 37.5%. VAS scores decreased significantly at three and six months, and Global Physical Health score increased significantly by three months. Conclusions MC reduces opioid prescription for patients with chronic OA pain and improves pain and quality of life.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Pharmacology & Pharmacy
Logo image